Nocipoint Therapy Versus Standard Physical Therapy Using Electrical Stimulation in Treating Pain From TMJ Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01676129|
Recruitment Status : Unknown
Verified August 2012 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted : August 30, 2012
Last Update Posted : August 30, 2012
|Condition or disease||Intervention/treatment||Phase|
|Temporomandibular Joint Disorders||Procedure: Nocipoint Therapy Procedure: Physical Therapy||Not Applicable|
The prevalence of temporomandibular disorders (TMD) is about 20% to 60% of dental patients. Most patients suffer from myofascial pain (MFP) subtype of TMD. Analgesics, local muscle injection or oral appliance are often used to treat TMD-related MFP. Patients are also referred to physical therapists frequently. Many physical therapy (PT) modalities and techniques are applied to these patients, including non-invasive transcutaneous electrical nerve stimulation (TENS) using TENS devices. However, the exact application of TENS devices, including the location of the stimulation, duration and intensity of stimulation, is largely decided by physical therapists. Nocipoint Therapy, a unique combination of precise location, duration and intensity of TENS has been found to substantially relieve general myofascial pain and recover the muscle function with lasting effect.
In preliminary observations of clinical applications, Nocipoint Therapy has been found to rapidly and substantially relieve TMD-related MFP within 2-3 sessions of the treatment.
This clinical study compares the effect of Nocipoint Therapy on TMD with that of standard Physical therapy (PT). TENS will be used in the control group both as a part of the standard of care (i.e., PT) and as placebo.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||90 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||Comparing the Effect of Typical Electrical Stimulation Therapy With Nocipoint Stimulation Therapy on TMD-Related Myofascial Pain|
|Study Start Date :||July 2012|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||March 2013|
Experimental: Nocipoint Therapy
Nocipoint therapy (NT) follows rules of TENS stimulation in each session, all within the general FDA guidelines of TENS uses. The key points of Nocipoint Therapy include the following:
Procedure: Nocipoint Therapy
Other Name: Charles Koo's Pain Cure Therapy
Active Comparator: Physical Therapy
Patients in this group will be treated with comprehensive physical therapy program including typical electrical stimulation using a standard transcutaneous electrical nerve stimulation (TENS) device, manual myofascial release and postural correction exercise.
The application of TENS will follow general physical therapy guidelines, especially for TMD. Manual myofacial release will be applied on orofacial muscles and neck muscles.
TENS will serve both as a part of the standard of care and as placebo, as the same TENS device is used in both arms.
|Procedure: Physical Therapy|
- Visual Analog Scale (VAS) for pain [ Time Frame: Measurements will be taken before and after each session, and at the follow-up, which is about 4 to 6 weeks after the last session ]
VAS is measured before each treatment session and at the follow-up:
- VAS - overall
- VAS - most painful
- VAS - when biting hard food
- VAS - at maximal mouth opening range (MMO)
- VAS of pressure pain- measured at the three most painful pressure points.
1,2, and 5 are also measured after each treatment session.
- Maximal mouth opening range (MMO) [ Time Frame: Measurements will be taken before and after each session, and at the follow-up, which is about 4 to 6 weeks after the last session ]
- Quality of Life (QoL) [ Time Frame: Measurements will be taken before the first session and at the follow-up. ]SF-36
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01676129
|Contact: Wan-Ling Kuo, BSfirstname.lastname@example.org|
|Contact: Charlie Koo, PhDemail@example.com|
|National Taiwan University Hospital||Recruiting|
|Contact: Wan-Ling Kuo, BS +886-0919-306-856 firstname.lastname@example.org|
|Contact: Charles C. Koo, PhD +1-650-996-8168 email@example.com|
|Principal Investigator: Alex YJ Chen, DDS, PhD|
|Principal Investigator: Charles C Koo, PhD|
|Principal Investigator: Jau-Yih Tsauo, PhD|
|Principal Investigator:||Alex YJ Chen, DDS, PHD||National Taiwan University|
|Principal Investigator:||Charles C Koo, PhD||National Taiwan University and Pain Cure Center California|
|Principal Investigator:||Jau-Yih Tsauo, PhD||National Taiwan University|